FAQ

(trifluoromethyl)phenyldiazirinylfenpyroximate

Known as: TDF cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
01220062017

Related topics

Related topics

2 relations

Broader (2)

BenzoatesPyrazoles

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
(trifluoromethyl)phenyldiazirinylfenpyroximate
Benzoates
Pyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Natural History and Ecology of Soldier Beetles (Coleoptera: Cantharidae) in the Mexican Tropical Dry Forests.
Until today, most information about the natural history and ecology of soldier beetles came from temperate zones, mainly from… (More)
Is this relevant?
2017
2017
Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
Combination therapy has been recommended for the treatment of patients harboring multiple drug-resistant hepatitis B virus (HBV… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
OBJECTIVE Little clinical data are available regarding the optimal treatment of patients who harbour adefovir-resistant HBV… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 4
Is this relevant?
2016
2016
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
During the past decade, management of drug resistant chronic hepatitis B (CHB) has been a major issue. A series of new antiviral… (More)
  • table 1
Is this relevant?
2015
2015
[How long should therapy last?].
Neuer NRTI mit optimierter Langzeitverträglichkeit → Tenofoviralafenamid (TAF) ist ein neuer nukleotidaler Reverse-Transkriptase… (More)
Is this relevant?
2014
2014
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.
New nucleos(t)ide agents (NAs) [entecavir (ETV) and tenofovir (TDF)] have made hepatitis B immunoglobulin (HBIG)-sparing… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2012
2012
An Abundance of Choices: Comment on "Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes".
BACKGROUND Current guidelines give recommendations for preferred combination antiretroviral therapy (cART). We investigated… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
Studies were conducted to determine if there is a mechanistic basis for reports of suboptimal virologic responses and concerns… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
Tenofovir disoproxil fumarate (TDF) is renally excreted by a combination of glomerular filtration and active tubular secretion… (More)
Is this relevant?
2006
2006
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir.
The mutation RT-K65R confers resistance to tenofovir (TDF). Although its prevalence is increasing with the use of this drug… (More)
Is this relevant?